Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Alimentary Pharmacology & Therapeutics
|
October 5, 2024
Editorial: Prediction in Inflammatory Bowel Disease-Do the Answers Lie in Big Clinical Data?
Zachary Green, James J Ashton
The Lancet. Child & Adolescent Health
|
September 1, 2018
Gastro-oesphageal reflux in infants: what are we treating?
James J Ashton, R Mark Beattie
The Lancet. Child & Adolescent Health
|
February 21, 2020
Can risk stratification help reduce negative appendicectomy rates?
James J Ashton, R Mark Beattie
Alimentary Pharmacology & Therapeutics
|
September 19, 2019
Letter: anti-TNF therapy and intestinal resections in Crohn's disease-are we just delaying the inevitable?
James J Ashton, R Mark Beattie
Lancet (London, England)
|
April 3, 2019
Personalised therapy for inflammatory bowel disease
James J Ashton, R Mark Beattie
Journal of Pediatric Gastroenterology and Nutrition
|
December 7, 2017
Faecal Calprotectin: What Does This Mean for the Paediatric Inflammatory Bowel Disease Phenotype?
James J Ashton, R Mark Beattie
Journal of Pediatric Gastroenterology and Nutrition
|
July 14, 2021
Response to: Transition Services for Paediatric Inflammatory Bowel Disease: Ready for Asian Patients Yet?
James J Ashton, R Mark Beattie
The Lancet. Gastroenterology & Hepatology
|
September 24, 2017
Improving remission rates in newly diagnosed paediatric ulcerative colitis
James J Ashton, R Mark Beattie
The Lancet. Child & Adolescent Health
|
March 12, 2019
Screen time in children and adolescents: is there evidence to guide parents and policy?
James J Ashton, R Mark Beattie
Gastroenterology
|
June 23, 2019
Treatment of Active Crohn's Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral Nutrition
James J Ashton, R Mark Beattie
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Alimentary Pharmacology & Therapeutics
|
October 5, 2024
Editorial: Prediction in Inflammatory Bowel Disease-Do the Answers Lie in Big Clinical Data?
Zachary Green, James J Ashton
The Lancet. Child & Adolescent Health
|
September 1, 2018
Gastro-oesphageal reflux in infants: what are we treating?
James J Ashton, R Mark Beattie
The Lancet. Child & Adolescent Health
|
February 21, 2020
Can risk stratification help reduce negative appendicectomy rates?
James J Ashton, R Mark Beattie
Alimentary Pharmacology & Therapeutics
|
September 19, 2019
Letter: anti-TNF therapy and intestinal resections in Crohn's disease-are we just delaying the inevitable?
James J Ashton, R Mark Beattie
Lancet (London, England)
|
April 3, 2019
Personalised therapy for inflammatory bowel disease
James J Ashton, R Mark Beattie
Journal of Pediatric Gastroenterology and Nutrition
|
December 7, 2017
Faecal Calprotectin: What Does This Mean for the Paediatric Inflammatory Bowel Disease Phenotype?
James J Ashton, R Mark Beattie
Journal of Pediatric Gastroenterology and Nutrition
|
July 14, 2021
Response to: Transition Services for Paediatric Inflammatory Bowel Disease: Ready for Asian Patients Yet?
James J Ashton, R Mark Beattie
The Lancet. Gastroenterology & Hepatology
|
September 24, 2017
Improving remission rates in newly diagnosed paediatric ulcerative colitis
James J Ashton, R Mark Beattie
The Lancet. Child & Adolescent Health
|
March 12, 2019
Screen time in children and adolescents: is there evidence to guide parents and policy?
James J Ashton, R Mark Beattie
Gastroenterology
|
June 23, 2019
Treatment of Active Crohn's Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral Nutrition
James J Ashton, R Mark Beattie
Page
of 8